Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Coen Ysbrand Willink

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6531-0358; OpenAlex author ID A5092051687. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers

Papers 3

  1. Intratumoral Holmium-166 Microsphere Injection in Patients with Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center, Single-Arm, Open-Label Feasibil… Co-author DOI 10.1159/000545246↗
  2. Development of an Intratumoral Holmium Microsphere Injection Method in Ex Vivo Human Pancreatic Ductal Adenocarcinoma: A Preclinical Feasibility Study. Co-author DOI 10.3390/cancers17061028↗
  3. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review. Co-author DOI 10.1093/bjsopen/zrad052↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. J. Frank W. Nijsen · 3 shared papers, 2023–2025 · strength 0.78
  2. Martijn W.J. Stommel · 3 shared papers, 2023–2025 · strength 0.78
  3. Cees J. H. M. van Laarhoven · 2 shared papers, 2025 · strength 0.54
  4. John J. Hermans · 1 shared paper, 2025 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.